20.06.2011 • Videos

Thomas Gründemann of Ferak Berlin on Custom Synthesis Trends

Ferak Berlin CEO Thomas Grünemann took a few minutes at this year's Chemspec Europe in Geneva to talk to CHEManager Europe Editor-in-Chief Brandi Schuster about custom synthesis and his company's "one product per campaign" strategy.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read